Cancer clinical trials in the region Île-de-France
261 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT02912949
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Systemic Treatment-Naive
Hôpital Cochin (Paris ), Institut Curie - Paris (Paris), Hôpital Louis Pradel (Bron ), Centre Léon Bérard (Lyon)
Merus
Phase 2
Lung cancer
#NCT02912949
Locally Advanced
Metastatic
Systemic Treatment-Naive
Hôpital Cochin (Paris ), Institut Curie - Paris (Paris), Centre Léon Bérard (Lyon), Hôpital Louis Pradel (Bron )
Merus
Phase 2
Lung cancer
#NCT05609578
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
Chemotherapy
Immunotherapy
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
Targeted therapy
Targeted therapy
Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Larrey (Toulouse ), Hôpital Tenon AP-HP (Paris ), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Institut Paoli-Calmettes (Marseille) (and 5 more...)
Mirati Thérapeutique Inc.
Phase 2
Lung cancer
#NCT05856695
SCLC (Small Cell Lung Cancer)
Metastatic
Systemic Treatment-Naive
Centre Hospitalier d'Abbeville (Abbeville), Clinique de l'Europe d'Amiens (Amiens), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Universitaire de Bordeaux (Bordeaux) (and 22 more...)
Intergroupe Francophone de Cancérologie Thoracique
Phase 2
Lung cancer
#NCT04699188
NSCLC (Non-Small Cell Lung Cancer)
SCLC (Small Cell Lung Cancer)
Mesothelium
Locally Advanced
Metastatic
KRAS G12C
AKT
ALK
BRAF
EGFR
KRAS non G12C
MET
NTRK-1/2/3
PIK3CA
RET
ROS-1
TP53
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Centre Léon Bérard (Lyon), Hôpital de la Timone AP-HM (Marseille)
Novartis
Phase 2
Lung cancer
#NCT05200481
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ALK
Systemic Treatment-Naive
BRAF
EGFR
KRAS G12C
KRAS non G12C
MET
NTRK-1/2/3
RET
ROS-1
Targeted therapy
Targeted therapy
Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Hôpital Ambroise-Paré AP-HP (Boulogne-Billancourt), Hôpital Louis Pradel (Bron ), CHU Caen Normandie (Caen) (and 21 more...)
Intergroupe Francophone de Cancérologie Thoracique
Phase 2
Lung cancer
#NCT03739710
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Non-squamous NSCLC
Locally Advanced
Metastatic
Chemotherapy
Immunotherapy
Systemic Treatment-Naive
Hôpital Bichat - Claude Bernard - AP-HP (Paris), Institut Bergonié (Bordeaux), Institut Curie - Paris (Paris)
GlaxoSmithKline
Phase 1
Hôpital Pitié Salpêtrière - AP-HP (Paris)